Shareholders' Deficit (Tables)
|
9 Months Ended |
Sep. 30, 2024 |
|---|
| Shareholders’ Deficit [Line Items] |
|
| Schedule of Preferred Stock Activity |
During the nine months ended September 30, 2024
and 2023, Series B preferred stock activity is as follows:
| |
|
For the Nine Months Ended
September 30, 2024 |
|
|
For the Nine Months Ended
September 30, 2023 |
|
| |
|
Number of
Shares |
|
|
Amount |
|
|
Number of
Shares |
|
|
Amount |
|
| Balance at beginning of period |
|
|
1,144 |
|
|
$ |
1,203,967 |
|
|
|
1,000 |
|
|
$ |
1,037,201 |
|
| Shares issued for accrued compensation |
|
|
312 |
|
|
|
312,000 |
|
|
|
144 |
|
|
|
144,000 |
|
| Shares issued for compensation |
|
|
50 |
|
|
|
50,000 |
|
|
|
- |
|
|
|
- |
|
| Shares and accrued dividends forfeited |
|
|
(317 |
) |
|
|
(334,009 |
) |
|
|
- |
|
|
|
- |
|
| Dividends accrued |
|
|
- |
|
|
|
19,352 |
|
|
|
- |
|
|
|
16,996 |
|
| Balance at end of period |
|
|
1,189 |
|
|
$ |
1,251,310 |
|
|
|
1,144 |
|
|
$ |
1,198,197 |
|
During the nine months ended September 30, 2024
and 2023, Series C preferred stock activity is as follows:
| |
|
For the Nine Months Ended
September 30, 2024 |
|
|
For the Nine Months Ended
September 30, 2023 |
|
| |
|
Number of Shares |
|
|
Amount |
|
|
Number of Shares |
|
|
Amount |
|
| Balance at beginning of period |
|
|
15,150 |
|
|
$ |
1,621,160 |
|
|
|
17,290 |
|
|
$ |
1,803,731 |
|
| Conversion of Series C shares to common shares |
|
|
(600 |
) |
|
|
(60,000 |
) |
|
|
(2,140 |
) |
|
|
(214,000 |
) |
| Reclassification of stated value to notes payable upon conversion |
|
|
(8,000 |
) |
|
|
(800,000 |
) |
|
|
|
|
|
|
|
|
| Dividends accrued |
|
|
- |
|
|
|
19,754 |
|
|
|
- |
|
|
|
23,792 |
|
| Balance at end of period |
|
|
6,550 |
|
|
$ |
780,914 |
|
|
|
15,150 |
|
|
$ |
1,613,523 |
|
|
| Schedule of Activity Related to Non-Vested Shares |
The following table summarizes activity related
to non-vested shares:
| |
|
Number of
Non-Vested
Shares |
|
|
Weighted
Average
Grant Date
Fair Value |
|
| Non-vested, December 31, 2023 |
|
|
14,970,120 |
|
|
$ |
0.132 |
|
| Shares vested |
|
|
- |
|
|
|
- |
|
| Non-vested, September 30, 2024 |
|
|
14,970,120 |
|
|
$ |
0.132 |
|
|
| Warrant [Member] |
|
| Shareholders’ Deficit [Line Items] |
|
| Schedule of Warrant Activities |
Warrant activities for the nine months ended September
30, 2024 are summarized as follows: | |
| Number of
Warrants |
|
| Weighted
Average
Exercise
Price |
|
| Weighted
Average
Remaining
Contractual
Term (Years) |
|
| Aggregate
Intrinsic
Value |
|
| Balance Outstanding December 31, 2023 |
| |
34,000,000 |
|
| $ |
0.011 |
|
| |
2.73 |
|
| $ |
- |
|
| Expired |
| |
(800,000 |
) |
| |
- |
|
| |
- |
|
| |
- |
|
| Balance Outstanding September 30, 2024 |
| |
33,200,000 |
|
| $ |
0.01 |
|
| |
2.04 |
|
| $ |
- |
|
| Exercisable, September 30, 2024 |
| |
33,200,000 |
|
| $ |
0.01 |
|
| |
2.04 |
|
| $ |
- |
|
|
| Stock Options [Member] |
|
| Shareholders’ Deficit [Line Items] |
|
| Schedule of Stock Option Activities |
Stock option activities for the nine months ended
September 30, 2024 are summarized as follows: | |
| Number of
Options |
|
| Weighted
Average
Exercise
Price |
|
| Weighted
Average
Remaining
Contractual
Term (Years) |
|
| Aggregate
Intrinsic
Value |
|
| Balance Outstanding, December 31, 2023 |
| |
8,445,698 |
|
| $ |
0.40 |
|
| |
2.43 |
|
| $ |
- |
|
| Expired |
| |
(1,675,000 |
) |
| |
- |
|
| |
- |
|
| |
- |
|
| Balance Outstanding, September 30, 2024 |
| |
6,770,698 |
|
| $ |
0.44 |
|
| |
2.22 |
|
| $ |
- |
|
| Exercisable, September 30, 2024 |
| |
6,770,698 |
|
| $ |
0.44 |
|
| |
2.22 |
|
| $ |
- |
|
|